MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, INVA made $107,800K in revenue. $89,908K in net income. Net profit margin of 83.40%.

Income Overview

Revenue
$107,800K
Net Income
$89,908K
Net Profit Margin
83.40%
EPS
$1.08
Unit: Thousand (K) dollars
Revenue Breakdown
    • Long Acting Beta2Agonist Relvar ...
    • Xacduro
    • Giapreza
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenue
107,800 100,283 88,632 89,508
Cost of products sold (inclusive of amortization of inventory fair value adjustments)
--8,842 9,990
Cost of products sold (inclusive of amortization of inventory fair value adjustments)-Product
25,643 10,590 --
Amortization of acquired intangible assets
6,618 6,547 6,475 -
Gross profit
75,539 83,146 73,315 -
Selling, general and administrative
27,291 26,412 27,491 26,219
Amortization expense
---6,511
Research and development
13,670 7,983 4,396 3,551
Total operating expenses
40,961 34,395 31,887 -
Income from operations
34,578 48,751 41,428 -
Changes in fair values of equity method investments, net
30,751 13,082 -13,549 -18,231
Changes in fair values of equity and long-term investments, net
31,510 11,280 -65,299 -16,936
Interest and dividend income
5,472 4,925 4,538 5,500
Interest expense
4,015 4,663 4,711 5,807
Total expenses, net
---82,659
Other expense, net
-479 -777 -996 -914
Income before income taxes
97,817 72,598 -38,589 6,849
Income tax expense, net
7,909 8,910 7,995 5,636
Net income and comprehensive income
89,908 63,688 -46,584 1,213
Earnings per share, basic
1.3 1.01 -0.74 0.02
Earnings per share, diluted
1.08 0.77 -0.74 0.02
Weighted average number of shares outstanding, basic
69,058,000 62,865,000 62,709,000 62,569,000
Weighted average number of shares outstanding, diluted
84,964,000 84,452,000 62,709,000 62,951,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Long ActingBeta2Agonist Anoro$11,844K Long ActingBeta2Agonist Relvar Breo$51,508K ZEVTERA$113K Xerava$4,909K Xacduro$23,813K Giapreza$18,459K Total royalties$63,352K License And OtherRevenue$610K Product$47,294K Royalty$59,896K Less amortization ofcapitalized fees paid$3,456K Total revenue$107,800K Gross profit$75,539K Amortization of acquiredintangible assets$6,618K Cost of products sold(inclusive of amortization...$25,643K Interest and dividendincome$5,472K Changes in fair values ofequity and long-term...$31,510K Changes in fair values ofequity method...$30,751K Income from operations$34,578K Total operatingexpenses$40,961K Income before incometaxes$97,817K Other expense, net-$479K Interest expense$4,015K Research and development$13,670K Selling, general andadministrative$27,291K Net income andcomprehensive income$89,908K Income tax expense, net$7,909K

Innoviva, Inc. (INVA)

Innoviva, Inc. (INVA)